Table 3 Descriptive statistics on data from patients who completed and did not complete treatment
From: Obstacles to successful treatment of hepatitis C in uninsured patients from a minority population
| Â | Total (%) | Completeda (%) | Did not completea (%) |
|---|---|---|---|
N (216) | 216 (100%) | 189 (87.5%) | 27 (12.5%) |
Age at treatment, years [mean (sd)] (p-value 0.0081) | 56 (9.3)b | 56 (8.7)b | 50 (11.4)b |
Sex (p-value 0.0087) | |||
 Male | 109 (50%) | 89 (82%) | 20 (18%) |
 Female | 107 (50%) | 100 (93%) | 7 (7%) |
Race (p-value 1.0000) | |||
 White | 153 (71%) | 133 (87%) | 20 (13%) |
 Black | 59 (27%) | 52 (88%) | 7 (12%) |
 Asian/other | 4 (2%) | 4 (100%) | 0 (0%) |
Ethnicity (p-value 0.1608) | |||
 Hispanic | 123 (57%) | 111 (90%) | 12 (10%) |
 Non-Hispanic | 93 (43%) | 78 (84%) | 15 (16%) |
Race/ethnicity (p-value 0.2801) | |||
 Hispanic | 123 (57%) | 111 (90%) | 12 (10%) |
 Non-Hispanic white | 38 (18%) | 30 (79%) | 8 (21%) |
 Non-Hispanic black | 52 (24%) | 45 (87%) | 7 (13%) |
 Asian/other | 3 (1%) | 3 (100%) | 0 (0%) |
Compliance (p-value < 0.0001) | |||
 Yes | 165 (76%) | 156 (95%) | 9 (5%) |
 No | 51 (24%) | 33 (65%) | 18 (35%) |
Complications (p-value 0.4402) | |||
 Yes | 111 (51%) | 99 (89%) | 12 (11%) |
 No | 105 (49%) | 90 (86%) | 15 (14%) |
Insurance (p-value 0.4261) | |||
 Yes | 62 (29%) | 56 (90%) | 6 (10%) |
 No | 154 (71%) | 133 (86%) | 21 (14%) |
Pre-treatment viral load, IU/mL [median (range)] (p-value 0.6122) | 1,655,329 (840–166,211,511)c | 1,675,814 (840–166,211,511)c | 969,891 (12,710–15,600,000)c |
Genotype (p-value 0.4598) | |||
 1 | 174 (81%) | 153 (88%) | 21 (12%) |
 2 | 20 (9%) | 18 (90%) | 2 (10%) |
 3 | 15 (7%) | 11 (5%) | 4 (27%) |
 4 | 6 (3%) | 6 (100%) | 0 (0%) |
 Mixed | 1 (0.46%) | 1 (100%) | 0 (0%) |
Cirrhosis (p-value 0.3942) | |||
 Yes | 80 (37%) | 68 (85%) | 12 (15%) |
 No | 136 (63%) | 121 (89%) | 15 (11%) |